Hypopharynx and larynx cancers: Propositions for the selection and the delineation of peritumoral microscopic disease volumes (lymph nodes excluded);Cancer de l'hypopharynx et du larynx proposition de sélection et délimitation des volumes cibles microscopiques péri-tumoraux (aires ganglionnaires exclues)

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Lapeyre, M ^a   Bailly, C ^a   Toledano, I ^a   Montalban, A ^b   Russier, M ^b  

^a CENTRE JEAN PERRIN   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Atlas; Cancer; Clinical target volume; Conformal radiotherapy; CTV; Hypopharynx; Larynx

Indexed keywords

ARTICLE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; VOCAL CORD;

HUMANS; HYPOPHARYNGEAL NEOPLASMS; HYPOPHARYNX; LARYNGEAL NEOPLASMS; LARYNX; LYMPH NODES; NEOPLASM METASTASIS; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649770977     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70007-X     Document Type: Article

References (34)

1. Becker M., Burkhardt K., Dulguerov P., Allal A. Imaging of the larynx and hypopharynx. Eur J Radiol 2008, 66(3):460-479.
2. Bhide S.A., Gulliford S., Kazi R., El-Hariry I., Newbold K., Harrington K.J., et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol. 2009, 93(3):539-544.
3. Bidault F.J., Bourhis J., Luboinski B. [Building Clinical Target Volume in laryngeal cancers using knowledge about modes of invasion of each location]. Cancer Radiother. 2005, 9(4):271-279.
4. Caglar H.B., Tishler R.B., Othus M., Burke E., Li Y., Goguen L., et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008, 72(4):1110-1118.
5. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003, 55(2):312-321.
6. Chavaudra J., Bridier A. [Definition of volumes in external radiotherapy: ICRU reports 50 and 62]. Cancer Radiother. 2001, 5(5):472-478.
7. Eisbruch A., Foote R.L., O'Sullivan B., Beitler J.J., Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol. 2002, 12(3):238-249.
8. Eisbruch A., Gregoire V. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol. 2009, 19(1):43-52.
9. Eisbruch A., Levendag P.C., Feng F.Y., Teguh D., Lyden T., Schmitz P.I., et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys. 2007, 69(2 Suppl):S40-S42.
10. Eisbruch A., Schwartz M., Rasch C., Vineberg K., Damen E., Van As C.J., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys. 2004, 60(5):1425-1439.
11. Feng F.Y., Kim H.M., Lyden T.H., Haxer M.J., Feng M., Worden F.P., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007, 68(5):1289-1298.
12. Gregoire V. [Target-volume selection and delineation in the cervico-maxillo-facial region: beyond the concepts of the ICRU]. Cancer Radiother. 2002, 6(Suppl 1):29s-31s.
13. Gregoire V., Coche E., Cosnard G., Hamoir M., Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol. 2000, 56(2):135-150.
14. Gregoire V., Daisne J.F., Bauvois C., Coche E., Duprez T., Hamoir M., et al. [Selection and delineation of lymph node target volumes in head and neck neoplasms]. Cancer Radiother. 2001, 5(5):614-628.
15. Gregoire V., Daisne J.F., Geets X., Levendag P. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. Rays. 2003, 28(3):217-224.
16. Gregoire V., Eisbruch A., Hamoir M., Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006, 79(1):15-20.
17. Gregoire V., Levendag P., Ang K.K., Bernier J., Braaksma M., Budach V., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003, 69(3):227-236.
18. Harnsberger H.R. Handbook of head and neck imaging 1995, Mosby, St Louis.
19. Ho K.F., Fowler J.F., Sykes A.J., Yap B.K., Lee L.W., Slevin N.J. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult. Acta Oncol. 2009, 48(3):431-439.
20. Prescibing, recording, and reporting photon beam therapy 1999, ICRU, Maryland, Bethesda.
21. Prescibing, recording, and reporting photon beam therapy 1993, ICRU, Maryland, Bethesda.
22. Lapeyre M., Henrot P., Alfonsi M., Bardet E., Bensadoun R.J., Dolivet G., et al. [Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]. Cancer Radiother. 2005, 9(4):261-270.
23. Lee N., Xia P., Fischbein N.J., Akazawa P., Akazawa C., Quivey J.M. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003, 57(1):49-60.
24. Lee N.Y., O'Meara W., Chan K., Della-Bianca C., Mechalakos J.G., Zhung J., et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2007, 69(2):459-468.
25. Levendag P., Braaksma M., Coche E., van Der Est H., Hamoir M., Muller K., et al. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys. 2004, 58(1):113-123.
26. Liu W.S., Hsin C.H., Chou Y.H., Liu J.T., Wu M.F., Tseng S.W., et al. Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation. BMC Cancer. 2010, 10(1):102.
27. Million RR, J. CN, A. MA. Larynx - Hypopharynx. In: Cassisi RRMaNJ, editor. Managment of head and neck cancer. 2nd edition ed. Philadelphia: Lipipincott; 1994. p. 439-507.
28. Putz R., Pabst R. Sobotta, Atlas d'anatomie humaine, Tête, cou, membre supérieur 1999, Editions médicales internationales, Cachan. 20 éme ed ed.
29. Rancati T., Schwarz M., Allen A.M., Feng F., Popovtzer A., Mittal B., et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys. 2010, 76(3 Suppl):S64-S69.
30. Rouvière H., Delmas A. Anatomie humaine, Tête et cou 2002, Masson, Paris.
31. Salama J.K., Haddad R.I., Kies M.S., Busse P.M., Dong L., Brizel D.M., et al. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009, 75(3):725-733.
32. Studer G., Lutolf U.M., Davis J.B., Glanzmann C. IMRT in hypopharyngeal tumors. Strahlenther Onkol. 2006, 182(6):331-335.
33. Studer G, Peponi E, Kloeck S, Dossenbach T, Huber G, Glanzmann C. Surviving Hypopharynx-Larynx Carcinoma in the Era of IMRT. Int J Radiat Oncol Biol Phys. 2010;janv 5.in press.
34. Wittekind C., Greene F.L., Hutter R.V.P., Sobin L.H., Klimpfinger M. TNM Atlas 2006, Springer, UICC.